How do I safely stop taking Cymbalta (duloxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Safely Stop Cymbalta (Duloxetine)

Do not stop duloxetine abruptly—taper gradually over at least 2-4 weeks to minimize discontinuation syndrome, which can cause dizziness, nausea, headache, irritability, and other withdrawal symptoms. 1

Understanding Discontinuation Syndrome

Duloxetine discontinuation can produce significant withdrawal symptoms due to its relatively short half-life of approximately 12 hours 2. The FDA label explicitly warns against stopping duloxetine suddenly, as this may result in serious symptoms including 1:

  • Neurological symptoms: Dizziness, electric shock-like sensations, headache, paresthesias
  • Gastrointestinal symptoms: Nausea, vomiting, diarrhea
  • Psychiatric symptoms: Anxiety, irritability, insomnia, agitation
  • Physical symptoms: Sweating, fatigue

These symptoms can be severe enough to significantly impair function and quality of life if the medication is stopped too quickly 3.

Recommended Tapering Schedule

The standard approach is to taper duloxetine gradually over a minimum of 2-4 weeks 4, 3. Here's a practical algorithm:

For patients on 60 mg once daily:

  • Week 1-2: Reduce to 30 mg once daily
  • Week 3-4: Continue 30 mg once daily, then discontinue
  • Monitor closely for withdrawal symptoms throughout 1

For patients on higher doses (90-120 mg daily):

  • Week 1: Reduce by 30 mg (e.g., 120 mg → 90 mg)
  • Week 2: Reduce by another 30 mg (e.g., 90 mg → 60 mg)
  • Week 3: Reduce to 30 mg
  • Week 4: Continue 30 mg, then discontinue
  • Consider extending the taper if withdrawal symptoms emerge 5

For patients who are elderly, frail, or have had previous severe withdrawal reactions:

  • Use a slower taper extending beyond 4 weeks (e.g., 6-8 weeks total)
  • Reduce by smaller increments (e.g., 15-20 mg every 1-2 weeks)
  • Monitor more frequently 6

Special Circumstances Requiring Modified Tapering

If discontinuing due to adverse effects: A more rapid taper may be necessary, but maintain closer monitoring for both the adverse effect prompting discontinuation and withdrawal symptoms 4.

If switching to another antidepressant: Your healthcare provider may employ a cross-taper strategy, starting the new medication while gradually reducing duloxetine to minimize both withdrawal symptoms and gaps in therapeutic coverage 6, 1.

If the patient has been on duloxetine for less than 3 weeks: A shorter taper (1-2 weeks) may be sufficient, as discontinuation syndrome is less likely with brief exposure 4.

Critical Monitoring During Discontinuation

Monitor patients weekly during the taper for 1:

  • Withdrawal symptoms: Particularly dizziness, nausea, and mood changes
  • Return of original symptoms: Depression, anxiety, or pain may re-emerge
  • Suicidal ideation: Especially in patients with depression or anxiety disorders
  • Blood pressure and heart rate: May normalize after discontinuation

Common Pitfalls to Avoid

Never stop duloxetine abruptly unless there is a life-threatening adverse reaction (e.g., severe skin reactions, hepatic failure, serotonin syndrome) 1. Even then, close medical supervision is essential.

Do not assume all patients tolerate the same taper schedule—some patients are highly sensitive to dose reductions and require slower, more gradual tapers extending 6-8 weeks or longer 4.

Do not confuse withdrawal symptoms with relapse of the underlying condition—withdrawal symptoms typically emerge within days of dose reduction and improve over 1-2 weeks, whereas relapse develops more gradually 3.

Avoid concurrent discontinuation of other serotonergic medications without medical supervision, as this compounds withdrawal risk 1.

Managing Withdrawal Symptoms If They Occur

If significant withdrawal symptoms develop during tapering 3:

  • Temporarily return to the previous dose that was tolerated
  • Wait 1-2 weeks for symptoms to resolve
  • Resume tapering at a slower rate (smaller dose reductions or longer intervals between reductions)
  • Consider symptomatic treatment for specific symptoms (e.g., antiemetics for nausea, though avoid serotonergic antiemetics like ondansetron)

When to Seek Immediate Medical Attention

Contact your healthcare provider immediately if you experience 1:

  • Suicidal thoughts or behavior
  • Severe agitation or panic attacks
  • Severe dizziness or falls
  • Persistent vomiting leading to dehydration
  • New or worsening depression or anxiety that is intolerable

References

Research

Adverse reactions to duloxetine in depression.

Expert opinion on drug safety, 2011

Guideline

Duloxetine Scheduling and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cross-Tapering from Escitalopram to Duloxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What's the next step for a patient on duloxetine (cymbalta) 70mg/day with fluctuating depression and controlled anxiety?
What are the next steps for a patient with minimal improvement on Cymbalta (duloxetine) 60 mg and Lyrica (pregabalin) 200 mg three times a day?
What is the best course of action for a 93-year-old male patient taking Cymbalta (duloxetine) 60 mg daily who is exhibiting irritability and talking about guns and knives?
What should a patient taking duloxetine (Cymbalta) 30mg do if they want to increase their dose?
What is the recommended dose of Duloxetine (Cymbalta)?
What is the recommended treatment for patients with recurrent pleural effusions who have failed conservative management and have a reasonable life expectancy, specifically regarding pleurodesis?
What is the recommended dose of metronidazole for a 2-month-old infant?
What are the diagnosis and treatment options for a patient with suspected vitamin C (Vit C) deficiency?
What are the next steps for a 55-year-old female with difficulty breathing, hypertension on Lercanidipine (generic name) and Losartan (generic name), rosacea, sharp chest pain partially alleviated by Ibuprofen (Advil) (generic name: Ibuprofen), undocumented fever, and specific pain locations, with an allergy to Etoricoxib?
What could be causing my palpitations and chest pain, given that I'm an adult under significant stress?
How do you calculate auto peep (intrinsic positive end-expiratory pressure) using an inspiratory hold maneuver in a mechanically ventilated patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.